These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 19527078)

  • 1. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
    Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
    Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C.
    Vergara M; Bejarano G; Dalmau B; Gil M; Miquel M; Sanchez-Delgado J; Casas M; Puig J; Martinez-Bauer E; Dosal A; Lopez M; Moreno L; Valero O; Bella MR; Calvet X
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):826-33. PubMed ID: 26043289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy.
    Moustafa EF; Makhlouf N; Hassany SM; Helmy A; Nasr A; Othman M; Seif H; Darwish M; Hassan H; Hessen M
    Arab J Gastroenterol; 2017 Mar; 18(1):6-12. PubMed ID: 28262531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis.
    Hung CH; Lu SN; Wang JH; Lee CM; Chen TM; Tung HD; Chen CH; Huang WS; Changchien CS
    J Gastroenterol; 2003; 38(2):153-7. PubMed ID: 12640529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LOGIQ E9 Shear Wave Elastrography for Detection of Liver Fibrosis in Patients with Chronic Hepatitis C Virus.
    Abrams GA; Jamal H; Deeter WT; Patil N
    South Med J; 2016 Nov; 109(11):730-734. PubMed ID: 27812720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H; Cooper C; Murphy T; Klein MB
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C.
    Buğdacı MS; Korkmaz H; Demir A; Bıyık M; Temel T; Göktürk HS; Ozakyol A; Hatemi I; Baysal B; Karaca C; Sentürk H
    Turk J Gastroenterol; 2014 Oct; 25(5):539-45. PubMed ID: 25417616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utility of 2 biochemical models predictive of liver fibrosis grade in prison inmates with hepatitis C].
    Portilla J; López-Burgos A; Saiz-De-La-Hoya-Zamácola P; Sánchez-Payá J; Bedía-Collantes M; Faraco-Atienzar I; Lissen E
    Gastroenterol Hepatol; 2009; 32(6):387-94. PubMed ID: 19477553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive markers and predictors of severity of hepatic fibrosis in HCV patients at Sharkia Governorate, Egypt.
    el-Shorbagy E; Afefy AF; Ibrahem IA; Mangoud AM; Eissa MH; Sabee EI; Mahrous S; Abdel-Monem A; Ismail A; Morsy TA; Etewa S; Nor Edin E; Mostafa Y; Abouel-Magd Y; el-Sedawy M; Ragab H; el-Tokhy H; Hassan MI; Lakouz K; Abdel-Aziz K; el-Hady G; Saber M
    J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):459-78. PubMed ID: 15124753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C.
    Guéchot J; Trocmé C; Renversez JC; Sturm N; Zarski JP;
    Clin Chem Lab Med; 2012 Jan; 50(4):693-9. PubMed ID: 22505560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S; Antonsson L; Westin J; Lagging M
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.